图书简介
Offering focused, practical, and up-to-date content on immunotherapies used to treat a wide variety of cancer types, Clinical Immuno-Oncology covers the basic cellular and molecular mechanisms involved in cancer initiation and progression. The text reviews the development of tumor specific antigens and the challenges of developing cancer immunotherapies. Every effort is made to relate the fundamental aspects of host immunity to the efficacy of current immunotherapies and how they work in conjunction with the immune system to combat cancer. This foundational resource explains the basics of cancer immunotherapy, discusses best practices, and provides recommendations from experienced clinicians in the field. Dr. John E. Niederhuber and a team of expert contributing authors provide clinically focused information essential for integrating these new therapies into practice-making this an ideal resource for fellows, practitioners, and other cancer team members in medical oncology, radiation oncology, cancer surgery, immunology, and cancer research. Offers balanced and synthesized content on clinical science, clinical and translational research, and evidence-based practice for cutting-edge immunotherapies. Discusses clinical applications of immunotherapies in common types of cancer including melanoma, breast cancer, pancreatic cancer, colon and rectum cancer, prostate cancer, leukemias, and hematologic malignancies. Includes dedicated chapters on immune responses, innate immunity, active immunization against cancer, and cell-based therapies by leading experts. Covers key topics such as cancer immunotherapy in the presence of COVID-19, immunotherapeutics, new findings concerning the role of the microbiome in immunotherapy, advances in engineered cell-based therapies, and active immunization against cancer. An eBook version is included with purchase. The eBook allows you to access all of the text, figures and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud.
Tentative TOC: Introduction: Chapter 1.0 Development and Structure of the Lymphoid System embryologic development gross anatomy of the human immune system lymphatic endothelial cells, heterogeneity of, and lymph node microscopic structure lymph node function; afferent lymph cellular components role of the gut microbiome in immune system development specific functions related to the spread of cancer cancer-induced lymphangiogeneis; sentinel LNs Chapter 2.0 The Chemistry, Structure, and Function of Immunoglobulins immunoglobulin isotypes the structure of immunoglobulins the genetics of immunoglobulin diversity antibody-dependent cellular cytotoxicity heavy-chain C domain and role of glycosylation the development of humanized monoclonals Chapter 3.0 The Role of the Complement System in Cancer complement system activation pathways (classical, alternative and lectin) the role of complement activation in cancer progression complement regulatory proteins (CRPs) and cancer the role of compliment activation in the tumor microenvironment enhances tumor growth complement-dependent cytotoxicity in immune therapy of cancer formation of the membrane attack complex (MAC) potential application of anti-complement cancer therapies (C3aR/C5aR/IL-10 pathway) Chapter 4.0 Cancer as Non-Self 4.1 primary generator of tumor-specific transplantation type antigens 4.2 character of non-self, tumor associated antigens 4.3 immune surveillance - innate immunity 4.4 distinguishing between self and non-self 4.5 toll-like receptors (TLRs); soluble bioactive proteins such as cytokines and C’ proteins 4.6 NK cells Chapter 5.0 The Adaptive Immune Response in Cancer the diversity of active tumor antigen receptors target specificity without limits in cancer-receptor variability tumor antigen presentation; dendritic cells immune response stimulation against the cancer Cytotoxic T-cells and T-regulatory cells B-cells and antibodies Chapter 6.0 The Science of Innate Immunity 6.1 critical regulator of human inflammatory disease 6.2 anatomic and physiologic barriers to pathogens - cancer causing viruses 6.3 centrally a limited number of critical receptors 6.4 the character of the inflammatory response 6.5 lack of ability to form memory 6.5 role in activating subsequent adaptive immune response Chapter 7.0 Immune Surveillance 7.1 history of concept (Ilya Mechnikov 1908 Nobel Prize) 7.2 evidence for immune surveillance today 7.3 cancer in the immunocompromised host Chapter 8.0 Cancer - Avoiding Immune Detection 8.1 cancer and the presence of immune resistance 8.2 concept for the development of tumor cell tolerance Chapter 9.0 Active Immunization Against Cancer and Cell-based Therapies 9.1 infusing in-vitro expanded Tumor Infiltrating Lymphocytes (TILs) 9.2 infusing dendritic cells pre-loaded with tumor specific oligopeptide antigens 9.3 B7 co-activating receptor 9.4 vaccines Chapter 10.0 The Three Major Clinical Components of Cancer Immunotherapy (modulating cell-mediated immune mechanisms) 10.1 the role of and application of check point blockade 10.2 the role and application of cell-based therapies including CAR-T cell therapies 10.3 antibodies (and vaccines); monoclonal antibodies and novel application of bi- or tri-specifics Chapter 11.0 The Clinical Application of Immunotherapeutics 11.1 in melanoma cancer 11.2 in breast cancer 11.3 in pancreatic cancer 11.4 in colon and rectum cancer 11.5 in prostate cancer 11.6 in leukemias and hematologic malignancies 11.7 in other malignancies Chapter 12.0 Cancer Immunotherapy in the Presence of COVID-19 12.1 immune response to coronavirus-2 infection 12.2 CD8 T cell depression during chronic viral infection and cancer 12.3 checkpoint inhibitors in cancer patients with coronavirus infection 12.4 coronavirus depletion of CD4 T cells
Trade Policy 买家须知
- 关于产品:
- ● 正版保障:本网站隶属于中国国际图书贸易集团公司,确保所有图书都是100%正版。
- ● 环保纸张:进口图书大多使用的都是环保轻型张,颜色偏黄,重量比较轻。
- ● 毛边版:即书翻页的地方,故意做成了参差不齐的样子,一般为精装版,更具收藏价值。
关于退换货:
- 由于预订产品的特殊性,采购订单正式发订后,买方不得无故取消全部或部分产品的订购。
- 由于进口图书的特殊性,发生以下情况的,请直接拒收货物,由快递返回:
- ● 外包装破损/发错货/少发货/图书外观破损/图书配件不全(例如:光盘等)
并请在工作日通过电话400-008-1110联系我们。
- 签收后,如发生以下情况,请在签收后的5个工作日内联系客服办理退换货:
- ● 缺页/错页/错印/脱线
关于发货时间:
- 一般情况下:
- ●【现货】 下单后48小时内由北京(库房)发出快递。
- ●【预订】【预售】下单后国外发货,到货时间预计5-8周左右,店铺默认中通快递,如需顺丰快递邮费到付。
- ● 需要开具发票的客户,发货时间可能在上述基础上再延后1-2个工作日(紧急发票需求,请联系010-68433105/3213);
- ● 如遇其他特殊原因,对发货时间有影响的,我们会第一时间在网站公告,敬请留意。
关于到货时间:
- 由于进口图书入境入库后,都是委托第三方快递发货,所以我们只能保证在规定时间内发出,但无法为您保证确切的到货时间。
- ● 主要城市一般2-4天
- ● 偏远地区一般4-7天
关于接听咨询电话的时间:
- 010-68433105/3213正常接听咨询电话的时间为:周一至周五上午8:30~下午5:00,周六、日及法定节假日休息,将无法接听来电,敬请谅解。
- 其它时间您也可以通过邮件联系我们:customer@readgo.cn,工作日会优先处理。
关于快递:
- ● 已付款订单:主要由中通、宅急送负责派送,订单进度查询请拨打010-68433105/3213。
本书暂无推荐
本书暂无推荐